People
Shares of Alexion Pharmaceuticals have jumped nearly 5% after the company’s board of directors rejected a push for a sale of the company from one of its largest stakeholders, U.K.-based Elliott Advisors, Ltd.
Veritas Genetics was offering whole-genome sequencing for about $600, going head-to-head with companies like 23andMe and Ancestry.com. Earlier this week there were reports the company laid off 50 staffers and now they’ve announced they are ending operations in the U.S.
Inceptua announced that Paul Wituschek has been appointed President North America.
Pharma and biotech companies strengthen their leadership teams and boards with this week’s hires.
The analysis found 13 key problems, but one of the most relevant is that the stated purpose of the research—which is also under attack—did not occur.
Phoenix Solutions AS, a clinical-stage biotech company, announced the appointment of Dr. Jean-Michel Cosséry to its Board of Directors.
InDevR, Inc., a life science tools company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, announced that Ms. Terry Salyer has joined the company as Chief Commercial Officer.
Researchers from around the world are coming to present scientific research and clinical trial data for the disease.
Richard Sackler, the former president of Purdue Pharma, wanted prescribers to know that when it comes to treating pain, OxyContin was the way to go. And, in order to boost those sales, that meant the company had to downplay any concerns regarding the risk of addiction.
Experienced financial leader joins Xenikos as they enter the final stage of clinical development of T-Guard®
PRESS RELEASES